DRTSW Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer

2 days ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer

3 days ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau to Participate in December Investor Conferences

13 days ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update

7 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau to Participate in May Investor Conferences

9 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau to Participate in March Investor Conferences

23 days ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau to Participate at Jefferies Global Healthcare Conference in London

a month ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness

a month ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness

3 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial

3 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial

3 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau to Participate in Five September Investor Conferences

4 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update

6 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau to Present at Jefferies Global Healthcare Conference

7 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

7 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors

7 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

7 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS ORMP

Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

8 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

8 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

9 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update

9 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification

9 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification

10 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

10 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

10 months ago - By: Alpha Tau Medical Ltd. - Mentions: DRTS